from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0272c/-

LFCtreatmentdescriptionclass of inhibitor

-0.726

Amikacinug/mL Amikacintranslation

-1.973

Cap5-10ug/mL Capreomycintranslation

-2.309

Rox10-50 ug/mL Roxithromycintranslation

-1.347

SM2-5 ug/mL Streptomycintranslation

-0.532

Tet5-10 ug/mL Tetracyclinetranslation

0.779

Rif0.2-5ug/mL Rifampicintranscription

-0.743

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.872

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.022

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.267

CPZ10-50 ug/mL Chlorpromazinerespiration

1.023

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.018

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.555

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.583

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.794

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.080

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.798

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.551

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.222

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.522

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.093

KCN5-20 ug/mL Potassium cyaniderespiration

-0.078

NaN30.2-2 mM Sodium aziderespiration

-0.173

Nigericin50 uM Nigericinrespiration

0.687

TRC10-150 ug/mL Triclosanrespiration

0.318

TRZ10-25 ug/mL Thioridazinerespiration

-0.245

Valinomycin0.5-10 uM Valinomycinrespiration

-1.154

ZnSO42 mM ZnSO4respiration

-0.982

menadione6-10 ug/mL Menadionerespiration

-0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.210

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.574

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.163

NRP_1Non-replicating persistence stage 1dosRassociated

-0.513

Amp0.2mg/mL AmpicillincellWall

-0.947

Cephalexin20-100 ug/mL CephalexincellWall

-0.698

Cerulenin0.32-5 ug/mL CerulenincellWall

0.273

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.066

EMB10-20 ug/mL EthambutolcellWall

-0.865

Eta12-40 ug/mL EthionamidecellWall

-0.923

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.973

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.519

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.553

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.572

BZA0.12 mg/mL BenzamidearomaticAmides

0.822

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.514

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.355

H2O24 mM hydrogen peroxideDNAdamaging

-0.608

Levo10 ug/mL LevofloxacinDNAdamaging

0.120

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.742

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.759

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.762

UVUV-irradiationDNAdamaging

-0.508

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.276

Antimycin12.5-50 ug/mL Antimycin A?

-0.127

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.112

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.332

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.124

PA8240.2-2 ug/mL PA-824?

0.753

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.243

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.124

Verapamil50 uM Verapamil?

0.360

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.436

methoxatin10-20 ug/mL Methoxatin?